More on CELG

- Summary
- Chart
- Profile
- Historical


- Earnings
- Ratings
- Holders


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/24/15 *Est.)
- Conference (6/9/2015)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

CELG Income Statement

Click line-items for a historical chart and %
Net product sales 1.96B
Collaborative agreements and other revenue 2.2M
Royalty revenue 23.2M
Total revenue 1.98B
Cost of goods sold (excluding amortization of acquired intangible assets)
Research and development 675.1M
Selling, general and administrative 497.6M
Amortization of acquired intangible assets
Acquisition related (gains) charges and restructuring, net 1.5M
Total costs and expenses 1.34B
Operating income 646.6M
Other income and expense:
Interest and investment income, net 6.9M
Equity in (gains) losses of affiliated companies
Interest expense -53.5M
Other income, net -22.5M
Income before income taxes 577.5M
Income tax provision 69M
Net income 508.5M
Less: Net loss attributable to non-controlling interest
Net income attributable to Celgene
Net income per share attributable to Celgene:
Basic 0.64
Diluted 0.61
Weighted average shares:
Basic 799.6M
Diluted 832.8M